Inventor · disambiguated record
David Hone
Also filed as: HONE DAVID · HONE DAVID M · HONE DAVID MICHAEL
26 granted patents·13 pending applications·921 citations·filing 1995–2015
97Inventor score
Files withUNIV MARYLAND BIOTECH INST9UNIV MARYLAND7AERAS GLOBAL TB VACCINE FOUND5HONE DAVID4AERAS GLOBAL TB VACCINE FOUNDATION3
Top patents by PatentIndex Score
39 records- 0197US6500419B1Method for introducing and expressing RNA in animal cellsUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Dec 31, 2002·170 cites·50 claims
- 0295US8012467B2Multivalent vaccines comprising recombinant viral vectorsCRUCELL HOLLAND BV·Filed 2005·Granted Sep 6, 2011·18 cites·19 claims
- 0395US5877159AMethod for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the sameUNIV MARYLAND·Filed 1995·Granted Mar 2, 1999·229 cites·24 claims
- 0492US7393525B2Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the sameUNIV MARYLAND·Filed 2003·Granted Jul 1, 2008·31 cites·5 claims
- 0590US7829104B2Electroporation of Mycobacterium and overexpression of antigens in mycobacteriaAERAS GLOBAL TB VACCINE FOUND·Filed 2007·Granted Nov 9, 2010·11 cites·5 claims
- 0690US7666656B2Recombinant BCG strains with enhanced ability to escape the endosomeAERAS GLOBAL TB VACCINE FOUND·Filed 2007·Granted Feb 23, 2010·17 cites·27 claims
- 0790US6150170AMethod for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the sameUNIV MARYLAND·Filed 1998·Granted Nov 21, 2000·103 cites·15 claims
- 0889US7850958B2Recombinant double stranded RNA nucleocapsid and use of the sameUNIV MARYLAND BIOTECH INST·Filed 2009·Granted Dec 14, 2010·3 cites·1 claims
- 0989US6759241B1Adjuvant comprising a lipopolysaccharide antagonistUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Jul 6, 2004·54 cites·55 claims
- 1089US5997881AMethod of making non-pyrogenic lipopolysaccharide or AUNIV MARYLAND·Filed 1996·Granted Dec 7, 1999·74 cites·19 claims
- 1187US7569219B2Recombinant double-stranded RNA phage, and use of the sameUNIV MARYLAND BIOTECH INST·Filed 2006·Granted Aug 4, 2009·4 cites·10 claims
- 1287US6548287B1Non-pyrogenic bacterial strains and use of the sameUNIV MARYLAND·Filed 1999·Granted Apr 15, 2003·66 cites·9 claims
- 1386US7125718B2Method for introducing and expressing genes in animal cells, and bacterial blebs for use in sameUNIV MARYLAND BIOTECH INST·Filed 2001·Granted Oct 24, 2006·18 cites·16 claims
- 1484US7407790B2Recombinant double-stranded RNA phages and uses thereofUNIV MARYLAND BIOTECH INST·Filed 2003·Granted Aug 5, 2008·9 cites·32 claims
- 1584US6682729B1Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the sameUNIV MARYLAND·Filed 1999·Granted Jan 27, 2004·51 cites·7 claims
- 1681US8043857B2Recombinant BCG strains with enhanced ability to escape the endosomeAERAS GLOBAL TB VACCINE FOUNDATION·Filed 2009·Granted Oct 25, 2011·4 cites·10 claims
- 1781US7537769B2Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxinAERAS GLOBAL TB VACCINE FOUND·Filed 2006·Granted May 26, 2009·4 cites·14 claims
- 1881US7018835B2Recombinant double-stranded RNA phage, and use of the sameHONE DAVID MICHAEL·Filed 2003·Granted Mar 28, 2006·10 cites·20 claims
- 1979US6596477B1Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid AUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Jul 22, 2003·11 cites·11 claims
- 2078US7625572B2Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteriaAERAS GLOBAL TB VACCINE FOUND·Filed 2005·Granted Dec 1, 2009·4 cites·29 claims
- 2176US8202723B2Multivalent vaccines comprising recombinant viral vectorsHAVENGA MENZO JANS EMCO·Filed 2011·Granted Jun 19, 2012·4 cites·19 claims
- 2275US8609402B2Multivalent vaccines comprising recombinant viral vectorsHAVENGA MENZO JANS EMCO·Filed 2011·Granted Dec 17, 2013·1 cites·18 claims
- 2370US7935354B2Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent stateAERAS GLOBAL TB VACCINE FOUNDATION·Filed 2007·Granted May 3, 2011·1 cites·6 claims
- 2469US8053568B2Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereofAERAS GLOBAL TB VACCINE FOUNDATION·Filed 2005·Granted Nov 8, 2011·1 cites·25 claims
- 2565US2007031382A1Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the sameUNIV MARYLAND·Filed 2006·Application pending·0 cites
- 2659US2011052628A1Recombinant Double-Stranded RNA Phage, and Use of the SameHONE DAVID·Filed 2010·Application pending·0 cites
- 2757US2009304750A1Novel prime-boost combinations of attenuated mycobacteriumHONE DAVID·Filed 2006·Application pending·0 cites
- 2854US2008107683A1Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses ThereofHONE DAVID·Filed 2007·Application pending·0 cites
- 2953US6841345B1Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid AUNIV MARYLAND BIOTECH INST·Filed 1999·Granted Jan 11, 2005·12 cites·17 claims
- 3053US2007059286A1Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activityHONE DAVID M·Filed 2003·Application pending·0 cites
- 3153US2004171565A1DNA vaccines that expresses mutant ADP-ribosyltransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activityFiled 2003·Application pending·0 cites
- 3253US2010047286A1Recombinant BCG strains with enhanced ability to escape the endosomeAERAS GLOBAL TB VACCINE FOUND·Filed 2005·Application pending·0 cites
- 3352US2006069052A1DNA vaccines that expresses mutant ADP-ribosyItransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activityHONE DAVID·Filed 2005·Application pending·0 cites
- 3452US2004120924A1Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid AFiled 2003·Application pending·0 cites
- 3551US6368604B1Non-pyrogenic derivatives of lipid AUNIV MARYLAND BIOTECH INST·Filed 1997·Granted Apr 9, 2002·11 cites·9 claims
- 3651US2006115494A1Recombinant BCG strains with attenuated immunosuppressive propertiesSUN RONGGAI·Filed 2005·Application pending·0 cites
- 3743US2002193330A1Genetically engineered co-expression DNA vaccines, construction methods and uses thereofFiled 2001·Application pending·0 cites
- 3842US2017274063A1Thermostable, chromatographically purified nano-vlp vaccineCARRA JOHN HOWARD·Filed 2015·Application pending·0 cites
- 3941US2010322951A1Replication-proficient dsRNA capsids and uses thereofBACILLIGEN INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Hone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →